Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
A phase II study of nivolumab (N) plus ipilimumab (I) in radioidine refractory differentiated thyroid cancer (RAIR DTC) with exploratory cohorts in anaplastic (ATC) and medullary thyroid cancer (MTC).
PaperCitations, authors & open-access status
A phase II study of nivolumab (N) plus ipilimumab (I) in radioidine refractory differentiated thyroid cancer (RAIR DTC) with exploratory cohorts in anaplastic (ATC) and medullary thyroid cancer (MTC). is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 65 citations, 2020 year and closed oa status.
65
Citations
2020
Year
closed
OA Status